Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05759208 · ClinicalTrials.gov registry record · Phase 2

The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease

A Phase 2 study of Dry Eye Disease, sponsored by Okyo Pharma.

Completed
Registry status
Phase 2
Development phase
240
Enrollment target
6
Study locations

NCT05759208 is a Phase 2 study of Dry Eye Disease that has completed, run by Okyo Pharma. The registered enrollment target is 240 participants, roughly in line with the 248-participant average among 33 other Dry Eye Disease trials with a reported enrollment target. The trial reports 6 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05759208, a Phase 2 study of Dry Eye Disease, has completed, sponsored by Okyo Pharma.

COMPLETED
Registry status
Phase 2
Development phase
240 participants
Enrollment target
6
Study locations

Study Summary

The objective of this study is to compare the safety and efficacy of OK-101 Ophthalmic Solution to placebo for the treatment of the signs and symptoms of dry eye.

Conditions Studied

Dry Eye Disease

Interventions

  • DRUG Placebo
  • DRUG OK-101

Study Locations (6)

California

  • Eye Research Foundation - Newport Beach

Colorado

  • Vision Institute - Colorado Springs

Kentucky

  • Butchertown clinical Trials - Louisville

Massachusetts

  • Andover Eye Associates - Andover

North Carolina

  • Core Inc. - Shelby

Tennessee

  • Total Eye Care, PA - Memphis

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2023-04-28
Est. Completion 2023-12-15
Phase Phase 2

Sponsor

Okyo Pharma

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05759208

The ClinicalTrials.gov registry entry for NCT05759208 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 248-participant average among 33 other Dry Eye Disease trials with a reported enrollment target. The listed sponsor is Okyo Pharma, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dry Eye Disease appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05759208 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Colorado, Kentucky.

Frequently Asked Questions

What is clinical trial NCT05759208 about?

NCT05759208 is a clinical study titled "The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease". The objective of this study is to compare the safety and efficacy of OK-101 Ophthalmic Solution to placebo for the treatment of the signs and symptoms of dry eye.

What is the current status of trial NCT05759208?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 240 participants. The study started on 2023-04-28. Estimated completion is 2023-12-15.

What conditions does trial NCT05759208 study?

This clinical trial studies the following conditions: Dry Eye Disease.

What interventions are being tested in trial NCT05759208?

The interventions under investigation include: Placebo (DRUG), OK-101 (DRUG).

Who is sponsoring clinical trial NCT05759208?

This trial is sponsored by Okyo Pharma, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05759208 being conducted?

This trial has 6 study locations across California, Colorado, Kentucky, Massachusetts, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Dry Eye Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Dry Eye Disease

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.